Dynamic susceptibility contrast perfusion MR imaging of multiple sclerosis lesions: characterizing hemodynamic

Yulin Ge1, Meng Law, Glyn Johnson

  • 1Department of Radiology, New York University School of Medicine, NY 10016, USA.

Abstract

Insights

Dynamic susceptibility contrast MRI reveals altered perfusion in multiple sclerosis (MS) lesions and normal-appearing white matter. These hemodynamic changes, including prolonged mean transit time, offer insights into MS pathogenesis and lesion development.

Area of Science:

  • Neurology
  • Radiology
  • Medical Imaging

Background:

  • Vascular pathology is frequently observed in multiple sclerosis (MS).
  • Perfusion measurement may elucidate MS pathogenesis and lesion development.
  • Hemodynamic changes are critical to understanding MS progression.

Purpose of the Study:

  • Investigate perfusion characteristics in MS lesions using dynamic susceptibility contrast MR imaging (DSC-MRI).
  • Understand hemodynamic changes in MS.
  • Correlate perfusion abnormalities with disease activity and lesion type.

Main Methods:

  • Seventeen patients with relapsing-remitting MS underwent DSC-MRI.
  • Perfusion parameters measured: cerebral blood flow (CBF), cerebral blood volume (CBV), and mean transit time (MTT).
  • Measurements were taken in enhancing lesions, non-enhancing lesions, normal-appearing white matter (NAWM), and control white matter.

Main Results:

  • MS lesions and NAWM showed significantly prolonged MTT compared to controls.
  • Enhancing lesions exhibited increased CBF and CBV, suggesting inflammation-driven vasodilation.
  • Non-enhancing lesions were heterogeneous: 63.8% showed decreased perfusion, while 36.2% displayed increased CBV.

Conclusions:

  • DSC-MRI can identify hemodynamic abnormalities in MS lesions related to inflammation and vascular compromise.
  • Perfusion patterns in non-enhancing lesions suggest microvascular abnormalities and inflammatory reactivity not visible on conventional MRI.
  • DSC-MRI provides valuable insights into the complex pathophysiology of MS lesions.